We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Vioxx Verdict Sets Dangerous Precedent for Merck, Analyst Says
Vioxx Verdict Sets Dangerous Precedent for Merck, Analyst Says
April 14, 2006
An analyst is warning that the $9 million in punitive damages awarded to another plaintiff last week in the Vioxx trial in New Jersey sets a dangerous “negative precedent” for future litigation against drugmaker Merck.